Northwest Biotherapeutics (NWBT) Release: Long-Term Data Updates Show Further Extensions of Survival and Delays in Recurrence in Brain Cancer Patients Who Received DCVax(R)-Brain
10/21/2009 9:16:23 AM
More...
|
Northwest Biotherapeutics (NWBT) Release: Long-Term Data Updates Show Further Extensions of Survival and Delays in Recurrence in Brain Cancer Patients Who Received DCVax(R)-Brain
10/21/2009 7:47:58 AM
More...
|
Northwest Biotherapeutics (NWBT) Update of Long-Term Data on Brain Cancer Patients Receiving DCVax(R)-Brain Continues to Show Striking Improvements in Delay of Disease and Survival
2/17/2009 10:18:36 AM
More...
|
Northwest Biotherapeutics (NWBT) Secures $700,000 Equity Financing
2/10/2009 10:36:33 AM
More...
|
Northwest Biotherapeutics (NWBT) Settles Class Action Complaint, and SEC Investigation Closed Without Action
1/9/2009 7:58:31 AM
More...
|
Northwest Biotherapeutics (NWBT) Reports Encouraging Data on First Patients Who Have Completed Its Phase I/II Clinical Trial of DCVax(R)-L in Metastatic Ovarian Cancer
12/29/2008 10:22:00 AM
More...
|
Northwest Biotherapeutics (NWBT) Secures US$0.5 Million Debt Financing
12/29/2008 9:36:09 AM
More...
|
Northwest Biotherapeutics (NWBT) Secures US$1.65 Million Debt Financing
11/6/2008 10:57:06 AM
More...
|
Northwest Biotherapeutics (NWBT) Secures US$1.0 Million Debt Financing
10/3/2008 11:14:26 AM
More...
|
Northwest Biotherapeutics (NWBT) Long-Term Phase I and Phase I/II Trial Data Continue to Show Striking Improvement in Survival of Brain Cancer Patients Who Receive DCVax(R)-Brain
9/11/2008 9:27:05 AM
More...
|
|